来源：新浪港股 10月15日，次新股傲迪玛汽车午后继续拉升，涨幅扩大至239%，报2港元，市值突破17亿港元，该股上市三日涨逾 730%。2亿市值炒到17亿，傲迪玛是怎样的存在？ 傲迪玛汽车是新加坡的一站式汽车售后服务提供商，主要从事提供全面的汽车售后服务，专注于检测、保养及维修服 务。 据弗若斯特沙文报告，按2018年新加坡独立汽车售后服务提供商提供汽车售后服务产生的收益计，该集团名列第一， 占有市场份额约8.4%。若按2018年新加坡汽车售后服务产生的收益计，该集团名列第三，占市场份额约5.3%。 根据弗若斯特沙利文报告公司2016年至2018年收益分别为1633.5万、1864.1万、1798.5万新加坡元，2016年及2017年溢 利分别为142.9万、190.6万新加坡元，2018年亏损24.3万新加坡元。 公司此次发售2.5亿股，其中配售1.75亿股，公开发售7500万股，每手10000股，净筹约2220万港元；公开发售获大幅 超额认购，相当于公开发售项下初步可供认购合共公开发售股份约28.18倍。 有人高歌有人哭 随着这只股票不断被炒作，股价涨了逾7倍。有些股民则悔断了肠子。有些股民开始怀疑"车 ...

Core Insights - The vision correction industry in China is experiencing rapid growth driven by policy support, market demand, and technological innovation [1][5][22] - The market size is projected to reach 215 billion yuan in 2024, with a year-on-year growth of 11.6% [1][14] - The industry has established a comprehensive treatment system combining surgical and optical correction methods [1][10] Policy Support - The Chinese government has implemented a series of policies to enhance eye health, including the "Comprehensive Prevention and Control of Myopia in Children and Adolescents Implementation Plan" [5][7] - Policies aim to create a management system covering prevention, treatment, and rehabilitation, promoting standardized and high-quality development in the industry [5][22] Market Demand - The number of myopic individuals in China has surpassed 600 million, with a significant increase in myopia rates across all age groups [8][12] - The myopia rate among high school students exceeds 80%, and projections suggest that the rate for the 16-24 age group may reach 94% [8][12] - This growing patient base provides a continuous driving force for the industry's development [1][8] Industry Structure - The vision correction industry has formed a complete industrial chain, with upstream focusing on optical materials and high-end equipment, while midstream includes the production of glasses and surgical devices [10][20] - The downstream market is served by medical institutions, optical centers, and e-commerce platforms, with private eye hospitals contributing over 60% of refractive surgeries [10][12] Competitive Landscape - The industry features a multi-layered competitive structure, with foreign brands dominating high-end markets while domestic brands accelerate their presence [20][21] - Key players include Aier Eye Hospital, Aibo Medical, and Opcon Vision, each with distinct market positions and strategies [21][20] Future Trends - The industry is expected to continue expanding due to policy-driven demand and technological advancements, with a focus on full-cycle management of eye health [22][24] - Innovations such as AI-assisted surgeries and domestic alternatives to imported products are reshaping the competitive landscape [24][25] - The trend towards service accessibility is being driven by private institutions expanding into lower-tier cities and the growth of online sales channels [25][22]